|
|
Prepublished online as a Blood First Edition Paper on July 5, 2002; DOI 10.1182/blood-2002-01-0312.

Submitted February 5, 2002
Accepted June 18, 2002
Long-lived immature dendritic cells mediated by TRANCE-RANK interaction
Isabelle Cremer, Marie-Caroline Dieu-Nosjean, Sylvie Marechal, Colette Dezutter-Dambuyant, Sarah Goddard, David Adams, Nathalie Winter, Christine Menetrier-Caux, Catherine Sautes-Fridman, Wolf H Fridman, and Chris G F Mueller*
Institut des Cordeliers, INSERM Unite 255, Paris, France
Hopital Edouard Herriot, INSERM Unite 346, Lyon, France
Liver Unit Laboratories, Queen Elizabeth Hospital, Birmingham, United Kingdom
Unite de Genetique Mycobacterienne, Institut Pasteur, Paris, France
Centre Leon Berard, INSERM Unite 453, Lyon, France
* Corresponding author; email: chmuller{at}infobiogen.fr.
Immature dendritic cells (DC) reside in interstitial tissues (int-DC) or in the epidermis, where they capture antigen and thereafter, mature and migrate to draining lymph nodes (LN) where they present processed antigen to T-cells. We have identified int-DC that express both TRANCE (tumor necrosis factor-related activation-induced cytokine) and RANK (receptor activator of NF- B) and have generated these cells from CD34+ human progenitor cells using M-CSF. These CD34+-derived int-DC which are related to macrophages are long-lived but addition of soluble RANK leads to significant reduction of cell viability and Bcl-2 expression. This suggests that constitutive TRANCE-RANK interaction is responsible for CD34+-derived int-DC longevity. Conversely, CD1a+ DC express only RANK and are short-lived. However, they can be rescued from cell death either by recombinant soluble TRANCE or by CD34+-derived int-DC. CD34+-derived int-DC mature in response to LPS plus CD40 ligand (L) and become capable of CCL21/CCL19-mediated chemotaxis and naive T-cell activation. Upon maturation, they loose TRANCE, making them, like CD1a+ DC, dependent on exogenous TRANCE for survival. These findings provide evidence that TRANCE and RANK play an important role in the homeostasis of DC.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Kwan Tat, N. Amiable, J.-P. Pelletier, C. Boileau, D. Lajeunesse, N. Duval, and J. Martel-Pelletier
Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis
Rheumatology,
December 1, 2009;
48(12):
1482 - 1490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Chino, K. E. Draves, and E. A. Clark
Regulation of dendritic cell survival and cytokine production by osteoprotegerin
J. Leukoc. Biol.,
October 1, 2009;
86(4):
933 - 940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-B. O. Barbaroux, M. Beleut, C. Brisken, C. G. Mueller, and R. W. Groves
Epidermal Receptor Activator of NF-{kappa}B Ligand Controls Langerhans Cells Numbers and Proliferation
J. Immunol.,
July 15, 2008;
181(2):
1103 - 1108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lorenzo, M. Horowitz, and Y. Choi
Osteoimmunology: Interactions of the Bone and Immune System
Endocr. Rev.,
June 1, 2008;
29(4):
403 - 440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D H Adams, B Eksteen, and S M Curbishley
Immunology of the gut and liver: a love/hate relationship
Gut,
June 1, 2008;
57(6):
838 - 848.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Wang, Y. Liu, J. Wang, G. Ding, W. Zhang, G. Chen, M. Zhang, S. Zheng, and X. Cao
Induction of Allospecific Tolerance by Immature Dendritic Cells Genetically Modified to Express Soluble TNF Receptor
J. Immunol.,
August 15, 2006;
177(4):
2175 - 2185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bechetoille, V. Andre, J. Valladeau, E. Perrier, and C. Dezutter-Dambuyant
Mixed Langerhans cell and interstitial/dermal dendritic cell subsets emanating from monocytes in Th2-mediated inflammatory conditions respond differently to proinflammatory stimuli
J. Leukoc. Biol.,
July 1, 2006;
80(1):
45 - 58.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-H. Kwan, A.-M. Helt, C. Maranon, J.-B. Barbaroux, A. Hosmalin, E. Harris, W. H. Fridman, and C. G. F. Mueller
Dendritic Cell Precursors Are Permissive to Dengue Virus and Human Immunodeficiency Virus Infection
J. Virol.,
June 15, 2005;
79(12):
7291 - 7299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Tenca, A. Merlo, E. Merck, E. E. M. Bates, D. Saverino, R. Simone, D. Zarcone, G. Trinchieri, C. E. Grossi, and E. Ciccone
CD85j (Leukocyte Ig-Like Receptor-1/Ig-Like Transcript 2) Inhibits Human Osteoclast-Associated Receptor-Mediated Activation of Human Dendritic Cells
J. Immunol.,
June 1, 2005;
174(11):
6757 - 6763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Goddard, J. Youster, E. Morgan, and D. H. Adams
Interleukin-10 Secretion Differentiates Dendritic Cells from Human Liver and Skin
Am. J. Pathol.,
February 1, 2004;
164(2):
511 - 519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Chougnet
Role of CD40 Ligand dysregulation in HIV-associated dysfunction of antigen-presenting cells
J. Leukoc. Biol.,
November 1, 2003;
74(5):
702 - 709.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|